Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
Recursion, a biopharma company, uses a data-driven approach to drug discovery, launching four clinical trials and planning a fifth in oncology. Recursion's software platform, the Recursion OS, is used ...
Talk of AI is everywhere, especially in healthcare. Companies are flooding into the space, promising to solve age-old problems by revolutionizing how prescription drugs are made and sold. A very ...
SALT LAKE CITY--(BUSINESS WIRE)--Recursion Pharmaceuticals today announced its $12.9 million Series A round of funding, led by leading deep technology investor Lux Capital, with participation from ...
Web users searching for photos and cops looking for suspects in video already benefit from software that understands the content of images. Chris Gibson says it can also make it easier to find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback